MaxCyte Documenti
Documenti
0
Ticker
MXCT
ISIN
US57777K1060
MaxCyte SEC Filings
Tipo | Rapporto | Data |
|---|---|---|
| Nessun documento disponibile | ||
MaxCyte Documenti 2026
Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione MaxCyte (MXCT, ISIN: US57777K1060). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 0 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di MaxCyte.
MaxCyte Analisi delle Azioni
MaxCyte MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products.